We are live on ! Find out more
FA

Friess Associates Portfolio holdings

AUM $59.9M
1-Year Est. Return 3.42%
This Fund
S&P 500
This Quarter Est. Return
+9.07%
1 Year Est. Return
+3.42%
3 Year Est. Return
+255.77%
5 Year Est. Return
+639.06%
10 Year Est. Return
AUM
$1.37B
AUM Growth
+$7.21M
Cap. Flow
-$80.1M
Cap. Flow %
-5.84%
Top 10 Hldgs %
22.21%
Holding
150
New
33
Increased
35
Reduced
24
Closed
34

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$24.1M
2
EA icon
Electronic Arts
EA
+$19.5M
3
K
Kellanova
K
+$19.5M
4
TSN icon
Tyson Foods
TSN
+$17.7M
5
YETI icon
Yeti Holdings
YETI
+$17.4M

Sector Composition

Rank Sector Weight
1 Technology 26.85%
2 Consumer Discretionary 16.84%
3 Healthcare 13.99%
4 Industrials 13.15%
5 Communication Services 10.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LITE icon
51
Lumentum
LITE
$60.6B
$12.6M 0.92%
235,452
-138,221
-37% -$7.37M
LYFT icon
52
Lyft
LYFT
$6.22B
$12.1M 0.88%
183,500
+128,500
+234% +$7.73M
EXAS
53
DELISTED
Exact Sciences
EXAS
$11.6M 0.84%
98,110
AXGN icon
54
Axogen
AXGN
$2.46B
$11.4M 0.83%
574,802
+164,544
+40% +$3.52M
CUB
55
DELISTED
Cubic Corporation
CUB
$11.3M 0.83%
175,775
+1,854
+1% +$109K
AEO icon
56
American Eagle Outfitters
AEO
$2.99B
$11.2M 0.82%
661,834
-240,368
-27% -$4.87M
COHR icon
57
Coherent
COHR
$56.4B
$11.1M 0.81%
302,568
-67,025
-18% -$2.45M
MCHP icon
58
Microchip Technology
MCHP
$40.8B
$10.6M 0.78%
245,400
-135,890
-36% -$6.04M
GH icon
59
Guardant Health
GH
$21.3B
$10.6M 0.77%
+123,000
New +$9.39M
UBER icon
60
Uber
UBER
$146B
$9.74M 0.71%
+210,000
New +$8.91M
ENPH icon
61
Enphase Energy
ENPH
$5.2B
$9.24M 0.67%
506,779
-221,967
-30% -$3.05M
TDOC icon
62
Teladoc Health
TDOC
$1.21B
$9.12M 0.67%
137,303
-86,560
-39% -$5.04M
DAY
63
DELISTED
Dayforce
DAY
$8.95M 0.65%
178,299
+848
+0.5% +$42.9K
LEVI icon
64
Levi Strauss
LEVI
$9.48B
$8.62M 0.63%
412,878
+81,878
+25% +$1.8M
SMAR
65
DELISTED
Smartsheet Inc.
SMAR
$8.37M 0.61%
172,938
+2,355
+1% +$100K
PRAH
66
DELISTED
PRA Health Sciences, Inc.
PRAH
$8.16M 0.6%
82,338
+2,436
+3% +$232K
CDNA icon
67
CareDx
CDNA
$2.48B
$7.94M 0.58%
220,543
+17,845
+9% +$571K
KRNT icon
68
Kornit Digital
KRNT
$734M
$7.69M 0.56%
242,796
-596
-0.2% -$16.4K
FWONK icon
69
Liberty Media Series C
FWONK
$24.5B
$7.11M 0.52%
+196,515
New +$7.13M
WMGI
70
DELISTED
Wright Medical Group Inc
WMGI
$7.09M 0.52%
237,640
+3,241
+1% +$98.9K
PS
71
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
$6.33M 0.46%
208,712
+89,759
+75% +$2.88M
UPLD icon
72
Upland Software
UPLD
$13.1M
$6.29M 0.46%
13,805
-1,366
-9% -$625K
QNST icon
73
QuinStreet
QNST
$896M
$5.85M 0.43%
369,279
+40,159
+12% +$599K
ADUS icon
74
Addus HomeCare
ADUS
$2.17B
$5.81M 0.42%
77,503
+1,455
+2% +$101K
CRMT icon
75
America's Car Mart
CRMT
$29.3M
$5.68M 0.41%
65,974
-8,752
-12% -$805K

Similar funds

Friess Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Friess Associates held 150 positions worth $1.37B, up 0.53% from $1.36B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Friess Associates withdrew a net $80.1M in Q2 2019, closing 34 positions and reducing 24 holdings. Its most notable exit was Salesforce, an estimated $29.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Friess Associates opened a new position in Advanced Micro Devices worth $25.7M.

  • Friess Associates's largest Q2 2019 buy was Advanced Micro Devices: 846,361 shares worth $25.7M.
  • Friess Associates added most to Lyft in Q2 2019, an estimated $7.73M increase.
  • Friess Associates's biggest Q2 2019 reduction was Elanco Animal Health, cutting an estimated $16.2M.
  • Friess Associates fully exited Salesforce in Q2 2019, selling an estimated $29.8M.
  • Friess Associates's ten largest holdings make up 22% of its $1.37B portfolio in Q2 2019.
  • Friess Associates opened 33 new positions and closed 34 in Q2 2019.
  • Friess Associates's portfolio value rose 0.53% quarter-over-quarter to $1.37B.

Based on Friess Associates's 13F filing for Q2 2019, filed 14 Aug 2019.